Longeveron (LGVN)

Longeveron Stock Analysis & Ratings

LGVN Stock Chart & Stats

Day’s Range$7.2 - $8.35
52-Week Range$2.84 - $45.00
Previous Close$7.22
Average Volume (3M)3.98M
Market Cap$167.29M
P/E Ratio-9.1
Next EarningsAug 12, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score9
EPS (TTM)-0.87

Longeveron News

Currently, no data available
Please return soon. This page is being updated.




P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Longeveron’s price range in the past 12 months?
Longeveron lowest stock price was $2.84 and its highest was $45.00 in the past 12 months.
    What is Longeveron’s market cap?
    Longeveron’s market cap is $167.29M.
      What is Longeveron’s price target?
      The average price target for Longeveron is $14.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $14.00 ,the lowest forecast is $14.00. The average price target represents 75.00% Increase from the current price of $8.
        What do analysts say about Longeveron?
        Longeveron’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Longeveron’s upcoming earnings report date?
          Longeveron’s upcoming earnings report date is Aug 12, 2022 which is in 88 days.
            How were Longeveron’s earnings last quarter?
            Longeveron released its earnings results on May 13, 2022. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.225 by $0.055.
              Is Longeveron overvalued?
              According to Wall Street analysts Longeveron’s price is currently Undervalued.
                Does Longeveron pay dividends?
                Longeveron does not currently pay dividends.
                What is Longeveron’s EPS estimate?
                Longeveron’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Longeveron have?
                Longeveron has 20,910,000 shares outstanding.
                  What happened to Longeveron’s price movement after its last earnings report?
                  Longeveron reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.225. Following the earnings report the stock price went up 10.803%.
                    Which hedge fund is a major shareholder of Longeveron?
                    Among the largest hedge funds holding Longeveron’s share is Gamco Investors, Inc. ET AL. It holds Longeveron’s shares valued at 449K.


                      Longeveron Stock Analysis

                      Smart Score
                      Price Target
                      ▲(75.00% Upside)
                      Moderate Buy
                      The Longeveron stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description


                      Longeveron LLC is a biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and hypoplastic left heart syndrome (HLHS).

                      Similar Stocks
                      No data currently available

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis